MEDIFAUCON
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
26-08
micro format · 26 days late
2025
31-12
Financial
Highest result from 2023 to 2025net €136,315 ▲34.7%
The operating result of €176,664 and the net result of €136,315 are both a record.
31-12
Financial
Equity above €200,000equity €234,924 ▲138%
After 2 profitable years in a row, equity reaches €234,924.
26-09
micro format · 57 days late
2024
31-12
Financial
Back to profitnet €101,193
The net result is €101,193, after one loss-making year.
29-05
micro format · 63 days before the deadline
02-01
Gazette deed
IncorporationStarting capital €1,000 · Appointment: FAUCONNIER Justin (director) · Permanent representative: BEGA Chemseddine · Founder7 points ▸
Gazette deed
Incorporation
Starting capital €1,000 · Appointment: FAUCONNIER Justin (director) · Permanent representative: BEGA Chemseddine · Founder7 points ▸
- Founder, FAUCONNIER Justin
- Founding capital, €1,000
- Capital
- Registered office clause, “1070 Anderlecht, Rue Félicien Rops, 37B/Boîte 19” (deed in French)
- Director appointment, FAUCONNIER Justin (director (not named in the articles))
- Permanent representative, BEGA Chemseddine
- Incorporation, 20-12-2023
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank